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Functionalized gold nanoparticles are emerging as a promising nano carrier for targeted delivery of therapeutic 
molecules. The present study describes synthesis, characterization and intracellular delivery of gold nanoparticles (AuNPs) 
functionalized with L1 protein of human papilloma virus peptide (HPV) derived cell-penetrating peptide (CPP) conjugated 
with R9. HPV-R9 cell penetrating peptide conjugated with AuNPs (fAuNPs) was characterized using UV-visible and 
Fourier Transform Infrared (FTIR) spectroscopy, transmission electron microscopy, dynamic light scattering and zeta 
potential. The cellular uptake of fAuNPs was studied in Vero cells using fluorescence microscopy and flow cytometry. The 
fAuNPs displayed reversible low intracellular aggregation, ~20% cytotoxicity but high efficiency and stability in Vero cells. 
The cytokines study by real-time PCR was performed in 4T1 cells of the IL-4, IL-12 and IFN-, found to be upregulated in 
comparison to control. The functionalized gold nanoparticles cell penetrating peptide show good intracellular transport to the 
cellular destinations. Results of this study demonstrate that cell penetrating peptide can be used along with gold 
nanoparticles for therapeutics application, particularly cancer. 
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To achieve targeted delivery of biomolecules, several 
delivery vehicles have been developed including 
nanoparticles1-4. Most existing delivery vehicles are 
toxic to cells, and in most cases the primary uptake 
into the endosomal vesicle leads to inefficient release 
of fusion protein into the cytosol. Gold nanoparticles 
(AuNPs) have been reported to overcome these 
barriers5-7 and such AuNPs when functionalized with 
nucleic acids, drugs, antibodies, PEG8, siRNA or 
peptides8-10 exhibit low cytotoxicity and excellent bio 
distribution abilities. 
Cell-penetrating peptides (CPPs), most commonly 
used for conjugation with AuNPs, are short peptides 
with membrane translocation capability and are 
widely used to deliver therapeutic molecules, 
nanoparticles, siRNA and nucleic acid11. These 
peptides usually translocate through biological 
membranes by direct penetration, transient pores and 
macropinocytosis12. The most commonly used CPP is 
the commercially available HIV TAT (protein trans-
activator of transcription) peptide13 for delivery of 
macromolecules and/or drugs into the nucleus or 
cytoplasm. AuNPs functionalized with CPPs 
translocate to the cytoplasm and the nucleus14. Some 
small molecules and amino acids that contained the 
reactive group for further modifications, such as 
cysteine, glutathione to stabilized the AuNPs15. 
Recently, we characterized the novel cell 
penetrating peptide derived from human papilloma 
virus (HPV) in nucleic acid delivery (data not shown). 
The potential CPP is derived from the C-terminus of 
the L1 protein of HPV. Here, we tried to develop a 
nano delivery vehicle by conjugating cysteinylated 
cell penetrating peptide of Human Papilloma virus 
with AuNPs for delivery of biomolecules with 
enhanced cellular uptake. AuNPs have been reported 
to cause changes in the expression of cytokines 
including IL-4, IL-1β and TNF-alpha16. Hence, we did 
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cytokine profile of AuNPs and fAuNPs for the IL-4, 
IL-12 and IFN-γ was studied by means of real-time 
PCR in mouse mammary tumor cells (4T1). We 
hypothesized that fAuNPs could be used in the 
application of targeted drug delivery. 
 
Materials and Methods 
 
Initially, we synthesized the gold nano particle of 
10-13 nm size by citrate reduction method and 
conjugate the FITC labeled HPV-R9 peptide with 
AuNPs named functionalized gold nano particle 
(fAuNPs). The AuNPs and fAuNPs were 
characterized by zeta-sizer, Fourier Transform 
Infrared (FTIR), UV-visible spectroscopy. The 
fAUNPs were then transfected in Vero cells and after 
24 h the transfection efficiency was measured by 
fluorescence microscopy. The quantitative 
intracellular delivery of fAuNPs was measured by 
flow cytometry and cytotoxicity by MTT assay. 
Therefore, the CPP stabilized with AUNPs could be 
an ideal delivery vehicle for the various therapeutic 
strategies. The fAuNP displayed low intracellular 
aggregation and toxicity but significant efficiency and 
stability in Vero cells.  
 
Identification of cell-penetrating peptide 
HPV-type 16 L1 protein sequence (region 5703-
7307 bp) was analyzed using an in silico algorithm. 
The support vector machine (SVM)–based CPP 
prediction was performed with a CellPPD web server 
that predicts efficient cell-penetrating peptides17. The 
SVM + Motif prediction method was selected at an 
SVM threshold of 0.1 and a motif e-value of 106. 
 
Peptide synthesis and analysis 
The identified CPP from HPV (TATKRKKRKKC) 
and its fusion with R9 peptides yields HPV-R9 (TAT 
KRKKRKKGGGRRRRRRRRRC). It is synthesized 
by standard solid phase methodology using F-moc 
chemistry18. Precipitated peptides in crude forms are 
purified by reverse phase chromatography (RP-
HPLC) on a C18–semi-preparative column using a 
UFLC pump system (Shimadzu, Tokyo, Japan) fitted 
to a photo diode array (PDA) detector. The specific 
labelling at the N-terminus of both peptides is 
achieved by conjugating with the FITC before 
cleavage and deprotection of peptides from the resin. 
It was analyzed by RP-HPLC, and the molecular 
masses of HPV and HPV-R9 were 1347.7 and 
3027.99 g/mol, respectively. 
Cell culture 
Vero cells obtained from the National Centre for 
Cell Sciences (NCCS) in Pune, India and 4T1 
(mammary tumor cell line) obtained from ATCC 
India were grown and maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) with high glucose 
(Gibco, USA) and RPMI with 10% Fetal bovine 
serum, 100 U/mL penicillin, 100μg/mL streptomycin 
(Gibco, USA) and 10 mM HEPES buffer (Duchefa 
Biocheme, the Netherlands), respectively. The cells 
were maintained at 37ºC, 5% CO2atmosphere and 
95% relative humidity. 
 
Synthesis of AuNPs 
Gold nanoparticles were synthesized by means of 
reduction of HAuCl4 by sodium citrate
19. An aqueous 
solution of HAuCl4 (250 mL, 1.0 mM) was refluxed 
for 5-10 min, and a warm aqueous solution of sodium 
citrate (30 mL, 35 mM) was added. The reflux was 
continued for about 30 min until a deep red solution 
developed. The solution was then passed through a 
0.45 µm syringe filter to remove any precipitate and 
stored at 4ºC. 
 
Functionalization of AuNPs with peptides (fAuNPs) 
Peptide HPV-R9 (NH2-RRRRRRRRRGGGTATK 
RKKRKKC-Linker-Cys-CoNH2) wasconjugated to 
AuNPs by mixing 5 nM of AuNPs with different 
concentrations of peptide to optimize the peptide 
amount required for activation and avoid excessive 
peptide-induced precipitation. The mixture (5 mL 
AuNPs+10 µg peptide) was incubated for 24 h with 
gentle stirring and washed three times by 
centrifugation at 16000 ×g for 20 min, and then the 
pellet was resuspended in phosphate buffer, pH 7.4. 
To check for the absence of nonconjugated peptide,  
2 mL of the conjugated solution was centrifuged at 
16000 ×g for 30 min, evaporated to dryness and 
finally resuspended in HPLC grade water. Peptide-
Cys-AuNPs were first suspended in methanol through 
sonication to ensure the extraction of representative 
dispersion volumes. 
 
Characterization of fAuNPs 
The functionalization of AuNPs was assessed by 
UV-visible and FTIR spectroscopy, transmission 
electron microscopy and zeta potential. For UV-
visible spectroscopy, the spectra were collected at 
wavelengths of 400-700 nm for both AuNPs and 
fAuNPs separately. FTIR (Nicolet 6700 FTIR, 
Thermo Fisher) spectra were collected for AuNPs and 
fAuNPs with over 118 scans per sample at a 




resolution of 4 cm-1. Particle size analysis was 
performed using a Zetatrac instrument (Microtrac). 
TEM images were taken with a Phillips Biotwin 12 
transmission (FEI) electron microscope. 
 
Cellular uptake of fAuNPs 
 
Fluorescence microscopy 
The Vero cells were seeded at 2×105 cells per well 
and incubated overnight at 37ºC with 5% CO2. The 
cells were transfected with FITC-conjugated AuNPs 
and fAuNPs for 24 h, fixed in absolute alcohol, 




The Vero cells were seeded and processed for 
transfection in a similar way as in fluorescence 
microscopy. The cells were trypsinized, washed twice 
with PBS and processed for flow cytometry in an FL1 
filter (BD FACS Calibur). 
 
Cytotoxicity assessment of fAuNPs 
The cytotoxicity of the fAuNPs was assessed by 
MTT dye reduction assay. Vero cells were seeded at a 
density of 1×104cells/well in a 96-well plate using 
minimum essential medium (MEM) supplemented 
with 10% FBS, 2 mM L-glutamine and 1X penicillin- 
streptomycin. The cytotoxicity of peptides, AuNPs 
and fAuNPs was determined by MTT (3-(4,5-
dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) 
dye reduction assay using CellTiter 96®non-radio-
active cell proliferation assay (MTT) kit (Promega, 
Madison, WI, USA). The absorbance was measured at 
570 nm using a microplate reader (M5 plate reader). 
 
RT-PCR 
The AuNPs and fAuNPs (10 and 20 nm) were 
transfected in 4T1 cells, and 48 h after transfection 
the cells were harvested and cell pellet was dissolved 
in 1.0 mL of TRIzol reagent (Ambion, Life 
Technologies) and the total RNA was isolated as per 
manufacturer protocol. The purity and concentration 
of RNA were checked by a NanoDrop-2000 
spectrophotometer (Thermo Fisher Scientific Inc., 
Wilmington, DE, USA). One μg of RNA was reverse 
transcribed using a RevertAid™ First Strand cDNA 
Synthesis Kit (M/sMBI Fermentas Life Sciences, 
Maryland, USA) according to the manufacturer's 
protocol. qRT-PCR was performed using the SYBR 
Green-I master mix (SYBR Green chemistry), a two-
step RT- PCR kit (Brilliant III Ultra-Fast SYBR ® 
Green QPCR Master Mix" #600882) with 7500 fast 
instrument (Applied Biosystem). The passive 
reference dye ROX was used for normalization of the 
reporter signal (SYBR Green). GAPDH was 
employed as the internal control, as it has been found 
to be a suitable endogenous control20. A melting curve 
analysis was performed to determine the specificity of 
qRT-PCR. The fold change was calculated by 2-ΔΔct 




Synthesis and characterization of fAuNPs 
The AuNPs and fAuNPs were characterized by 
UV-visible spectroscopy and FTIR. The size of 
fAuNPs was measured by transmission electron 
microscopy (TEM) (Fig. 1A) The UV-visible spectra 
of AuNPs displayed a shift from 517 to 525 nm, 
indicating successful functionalization of the AuNPs 
(Fig. 1B). To reconfirm the UV-visible spectral shift, 
the AuNPs and fAuNPs were subjected to FTIR 
scanning. The size of the AuNPs after conjugation 
with HPV-R9 increased from 13 to 35.9 nm, 
indicating successful conjugation (Fig. 2). Once the 
AuNPs were modified with peptide ligands the colour 
of AuNPs changed from dark red to blue which 
indicate the aggregation. In case of HPV-R9 the 
fAuNPs maintained the red colour that indicative of 
no aggregation. The FTIR scans displayed a peak 
 
 
Fig. 1 — (A) Size of fAuNPs by TEM; and (B) Size confirmation 
of fAuNPs by dynamic light scattering (Zetasizer). 




difference between 1290 and 1120 cm-1, which 
confirmed the conjugation of peptide to AuNPs  
(Fig. 3), In addition, the fAuNPs were found to be 
stable for more than 2 months at 4ºC, with minute 
aggregates that segregated after gentle vortexing. This 
result reflects the reversible nature of cluster 
formation in the nanoparticles. 
 
Cellular uptake of fAuNPs 
The cellular uptake of fAuNPs in Vero cells by 
transfection was assessed and confirmed by 
fluorescence microscopy after 24 h of transfection 
(Fig. 4). The green fluorescence indicates the uptake 
of fAuNPs by the Vero cells and merged image with 
DAPI shows the localization of fAuNPs in the cells. 
The qualitative observations of fluorescence 
microscopy were further reinforced by flow 
cytometry (Fig. 5). As much as 71.42% of Vero cells 
were positive in fAuNPs compared to control 
(AuNPs) in concordance with the fluorescence 
microscopy results. 
 
Cell cytotoxicity assessment of fAuNPs 
The cytotoxicity of fAuNPs was evaluated in Vero 
cell transfected with fAuNPs and after 24 h p.t. cell 
viability was evaluated by MTT assay. It was 
observed that high concentration of fAuNPs (15nM), 
80% of the cells remained viable (Fig. 6). 
 
Expression profile of the cytokines 
The cytokines expression profiles of IL-4, IL-12 
and IFN-Ү were studied by real time PCR. The fold 
change of IL-4 was found to be upregulated in the 
AuNP control group as well as the 10 and 20 nm 
fAuNPs (1.70±1.00, 1.13±1.00 and 2.60±1.00), 
respectively. The fold change of IL-12 was found  
to be upregulated in 10 and 20 nm fAuNPs as 
compare to AuNPs control cells (0.385±1.00, 
1.064±1.00 and 2.700±1.00), respectively. The fold 
change of IFN-Ү was found to be upregulated in 
the10 and 20 nm fAuNPs as compared to the AuNPs  
 
 




Fig. 3 — Spectra of AuNPs; and functionalized nanoparticles 
(fAuNPs) characterization for their surface modification by FTIR. 
 





control 4T1 cells (0.918±1.00, 2.566±1.00 and 
1.484±1.00, respectively) (Fig. 7). 
 
Discussion 
AuNPs are suitable for delivery of drugs to cellular 
destinations due to ease of synthesis, functionalization 
and biocompatibility. Peptide-functionalized AuNPs 
have widely been studied elsewhere for the delivery 
of drug(s), nucleic acids and siRNAs22. To achieve 
optimum working potential in cellular applications, 
we have adopted strong methods for a controlled 
uptake of AuNPs into cells and downstream 
localization to the cytosol or specific cell organelles. 
The cationic polymer(s) or coating on AuNPs 
facilitates their entry into the cells due to the negative 
charges on the membrane. The cationic, arginine- 
rich CPPs have been reported to use predominantly 
direct penetration mechanisms23. The amino acid 
composition significantly alters the internalization  
of the peptide24. The cationic nature of arginine 
enhances the peptide’s internalization by disrupting 
the membranes of macropinosomes for access into  
the cytosol25. In this study, we designed a novel  
 
 




Fig. 5 — Cellular uptake of functionalized nanoparticles by flow 




Fig. 6 — Cell viability study after exposure of functionalized 
nanoparticles at different concentration in in vitro and evaluated 
by MTT assay. 
 
 
Fig. 7 — The gene expression profile of cytokines (IL-4, IL-12 
and IFN-Ү) in 4T1 cells by real-time PCR after exposure of 
fAuNPs with the size 10 and 20 nm 
 




CPP HPV-R9 conjugated with 13 nm AuNPs,  
which facilitate the cellular uptake in Vero cells  
and its localization in nucleus as well in cytoplasm 
too. Tiwari et al.26 demonstrated the uptake of  
VG-21 functionalized GNPs (fGNPs) in eukaryotic 
cell like HeLa, HEp2 and Vero cells. The conjugation 
of peptide on the surface of AuNPs was confirmed  
by UV-visible spectrum, FTIR and zeta-potential.  
In addition, the fAuNPs displayed very low 
cytotoxicity to the cell line tested, making them 
suitable as delivery vehicles in in vitro conditions. 
Several studies like modified amino acid 
functionalized with AuNPs (pY-AuNPs) suggest them 
to be potential drug target for cancer therapy with no 
cytotoxicity in cells27. The type-II interferons and 
interleukins were also found to be upregulated in 
fAuNPs treated cells showed that the cytokine 
profiling of the cells after AuNPs exposure. A 
chemically synthesized anticancer cell penetrating 
peptide SVS-1 has the ability to promote the rapid 
uptake of gold nano rods (AuNRs) and AuNPs in 
HeLa cells and translocated in to cells by non-
endocytotic pathway28. 
Furthermore, the nanoparticle diameter and surface 
coverage of the peptide affected both the 
internalization of nanoparticles and the sub-cellular 
target (nucleus or cytoplasm). The uptake of 
nanoparticles is related to the extent of aggregation, 
expression of target receptors, endocytosis 
mechanism and cell phenotypes29. The HPV-R9 
peptide showed less aggregation within and long-term 
stability in vitro. 
 
Conclusion 
We have reported first time the internalization of 
HPV-R9 peptide conjugated with AuNPs for 
intracellular delivery in cells. In this study, the 
fAuNPs conjugated with HPV-R9 peptide shows 
higher internalization in Vero cells suggesting  
that this CPP can be used for targeted delivery  
of therapeutics molecules into the cells. Also,  
these fAuNPs does not have any cytotoxic effect  
on the cells. It will enhance availability of 
therapeutics molecule at the site of diseases by 
increasing the uptake of modified nanoparticles  
by cells. Thus, this fAuNPs can be useful for changes 
in gene expression and might be used as a delivery 
system. 
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